While hallmark electromyography findings, symptomatic alleviation from benzodiazepine therapy, and the presence of autoantibodies against glutamic-acid-decarboxylase-65 (anti-GAD65) suggest SPS, diagnosis still relies on subjective clinical judgment, given the condition’s variable and poorly understood presentation [11, 12]. This evidence concerns the gene GAD2 and stiff-person syndrome.